Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Selegiline transdermal system in major depressive disorder: profile report.

× No keyword cloud information.

18 in total

Review 1. The medical management of depression.

Authors: J John Mann
Journal: N Engl J Med Date: 2005-10-27 Impact factor: 91.245

2. Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients.

Authors: J Alexander Bodkin; Jay D Amsterdam
Journal: Am J Psychiatry Date: 2002-11 Impact factor: 18.112

3. Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.

Authors: Alan D Feiger; Karl Rickels; Moira A Rynn; Dan L Zimbroff; Donald S Robinson
Journal: J Clin Psychiatry Date: 2006-09 Impact factor: 4.384

Review 4. Transdermal selegiline: the new generation of monoamine oxidase inhibitors.

Authors: Ashwin A Patkar; C-U Pae; Prakash S Masand
Journal: CNS Spectr Date: 2006-05 Impact factor: 3.790

5. Tranylcypromine versus imipramine in anergic bipolar depression.

Authors: J M Himmelhoch; M E Thase; A G Mallinger; P Houck
Journal: Am J Psychiatry Date: 1991-07 Impact factor: 18.112

6. MAOI efficacy and safety in advanced stage treatment-resistant depression--a retrospective study.

Authors: Jay D Amsterdam; Justine Shults
Journal: J Affect Disord Date: 2005-10-06 Impact factor: 4.839

7. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal: JAMA Date: 2003-06-18 Impact factor: 56.272

8. Global burden of depressive disorders in the year 2000.

Authors: T B Ustün; J L Ayuso-Mateos; S Chatterji; C Mathers; C J L Murray
Journal: Br J Psychiatry Date: 2004-05 Impact factor: 9.319

9. A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder.

Authors: Jay D Amsterdam
Journal: J Clin Psychiatry Date: 2003-02 Impact factor: 4.384

Selegiline transdermal system in major depressive disorder: profile report.